Litigation/Dispute Resolution and Patents©2020 Managing Intellectual Property60Litigation/Dispute Resolution and PatentsKnowIt comes to Las VegasKnowIt: Intellectual Property in a Digital World will be held at Aria Resort and Casino in Las Vegas between May 11-14. It will cover a number of panel discussions on various IP issues including AI, privacy and the ethics of innovation, 21 Feb 2020 10:00:00 GMTPTAB petition fall tied to broad litigation trendsLawyers at Unified Patents, 3M and a telecoms company say that while a 23% application fall in 2019 highlights the increased risk of filing at the PTAB, the numbers could bounce back, 17 Feb 2020 09:00:00 GMTTC Heartland still stifles plaintiffs and foreign firmsAlthough some US in-house counsel say three years has been enough time to adjust to the venue shopping ruling, others are still feeling the pinch, 14 Feb 2020 20:00:00 GMTChina IP Forum: Supreme Court IP vice president calls for punitive damages focusWang Chuang also sheds light on the trend to combine civil and administrative cases, and the development of the talent pipeline, 11 Feb 2020 08:15:00 GMTManaging IP Americas Awards 2020 shortlists announcedManaging IP reveals the shortlists for the Americas Awards 2020 ceremony, which will be held on March 26 at the Lotte New York Palace, New York City, 05 Feb 2020 09:30:00 GMTBiologics litigation raises remedy and external counsel concernsWith innovator-v-innovator cases growing, in-house counsel say they cannot always rely on trusted tactics for small molecule litigation, or even on some of their trusted law firm partners, 03 Feb 2020 09:00:00 GMTPTAB judges case unnerves some in-house counsel but leaves others unworriedWhile some businesses are watching Arthrex developments with bated breath, others believe it will have less impact – after the finding that PTAB judges are not constitutionally appointed, 31 Jan 2020 13:00:00 GMTBroad CRISPR loss shows how not to file a priority claimLife sciences in-house sources stress the importance of following the EPO’s strict priority claims guidelines after the Board of Appeal invalidated some of the Broad Institute’s CRISPR patents, 30 Jan 2020 11:30:00 GMTKings of Europe: why do the 'big four' dominate IP?As France, Germany, the Netherlands and the UK are generally considered Europe’s IP ‘powerhouses’, Managing IP asks why and considers whether similar-sized jurisdictions can compete, 29 Jan 2020 10:30:00 GMTPhilippines: IPOPHL posts proposed guidelines on compulsory licences, 20 Jan 2020 13:30:00 GMTChina apex court ruling will provide more patent consistencyNovel decision outlines ambitious step that China’s supreme court is taking to make it more efficient to enforce patent rights, 20 Jan 2020 07:00:00 GMTCannabis filers hash over FTO and future enforcementCounsel at Aphria, Cresco Labs, Aurora, Scientus Pharma and Canopy Growth say due diligence is becoming more important in their efforts to avoid infringement on copious new registrations, many of which are overly broad or hidden, 16 Jan 2020 14:00:00 GMTSEP remedy policy ‘reversal’ emboldens US patent ownersDespite having little legal impact, the Department of Justice’s and USPTO’s new joint policy statement on remedies for standard essential patents has encouraged many businesses in their FRAND negotiations, 16 Jan 2020 14:00:00 GMTUK SPC ruling pushes patent drafting specificityGenerics and innovator pharma companies welcome December’s SPC decision from a UK court, saying it further clarifies an uncertain regulation, but believe it will introduce prosecution challenges, 16 Jan 2020 14:00:00 GMTHong Kong: Original grant patent system is introduced, 15 Jan 2020 11:30:00 GMTMyanmar: Myanmar introduces new patent law, 15 Jan 2020 11:30:00 GMTTaiwan: Taiwan’s IP Court is reshaped, 14 Jan 2020 14:45:00 GMTBIP Asia: AI-related IP policies need more work globallyPatentability and sufficiency of disclosure remain unsettled issues that IP owners and offices are grappling with, according to AIPPI and private practice speakers, 13 Jan 2020 15:00:00 GMTSEP stakeholders want essentiality checks in 2020 to streamline negotiationsIn-house counsel say checks would be a good way to demonstrate that technologies are essential to a standard, but are not certain how they should be done or by which organisation, 09 Jan 2020 15:45:00 GMTLooking ahead to 2020: Lawyers contemplate key US patent casesPractitioners say that there could be significant IP shake-ups from the US Supreme Court, but that reform from Congress is unlikely, 09 Jan 2020 15:15:00 GMTIn-house roundup: Fintech win worries financials; businesses look to 2020 essentiality checksManaging IP rounds up the latest news and analysis from in-house counsel, 09 Jan 2020 15:00:00 GMTFirst patent win for bank puts financials on their toesA $200-million payment for USAA shows that financial companies are vulnerable to competitor patent claims and might need to build up their defensive portfolios, according to in-house counsel, 08 Jan 2020 16:00:00 GMTIP practitioners mull judicial shake-up to ease recruitment crisisSurvey respondents are not convinced that the England and Wales High Court has the resources to deal with future IP cases, yet lawyers and experts are divided on the best methods to improve recruitment, 08 Jan 2020 10:30:00 GMTDepriving others of their intellectual property, 18 Dec 2019 15:00:00 GMTRelief as SCOTUS swerves ‘radical departure’ in patent fees caseIn-house and private practice lawyers say the court has avoided creating a chilling effect on innovative businesses and note that the ruling will also affect trademark disputes, 18 Dec 2019 10:30:00 GMTAI alliances will push pharma refocus on patent bundles and licensingPharma companies say AI’s potential to make R&D models more efficient and less expensive will drive the development of therapeutics that require different IP strategies, 12 Dec 2019 16:30:00 GMTSeminal pay for delay law opposed by pharma companiesGenerics and innovator companies say they don’t like the new and ‘badly-worded’ legislation introduced by California that bans drug settlements and could actually raise drug prices, 12 Dec 2019 16:30:00 GMTIn-house roundup: Pay for delay opposed by all; AI spurs pharma IP refocus; energy digitalisation pushes patent overhaulManaging IP rounds up the latest news and analysis from patent-focused businesses, 12 Dec 2019 15:15:00 GMTIn-house roundup: anti-anti-suit injunction filers reveal insights; US-UK trade documents unpacked; open source case spurs NPE fearManaging IP rounds up the latest news and analysis from patent-focused businesses, 06 Dec 2019 09:00:00 GMTWhat the US-UK trade deal documents actually revealGenerics and innovator sources from the pharma industry explain why documents from US and UK trade discussions do not point to the US trying to extend pharmaceutical patents, 05 Dec 2019 17:00:00 GMT